bioRxivCancer Biology
Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients
P. Whitmire, C. R. Rickertsen, A. Hawkins-Daarud, E. Carrasco, J. Lorence, G. De Leon, L. Curtin, S. Bayless, K. Clark-Swanson, N. C. Peeri, C. Corpuz, C. P. Lewis-de los Angeles, B. R. Bendok, L. Gonzalez-Cuyar, S. Vora, M. Mrugala, L. S. Hu, L. Wang, A. Porter, P. Kumthekar, S. K. Johnston, K. M. Egan, R. Gatenby, P. Canoll, J. B. Rubin, K. R. Swanson
Abstract
BackgroundSex is recognized as a significant determinant of outcome among glioblastoma patients, but the relative prognostic importance of glioblastoma features has not been thoroughly explored for sex differences.\n\nMethodsCombining multi-modal MR images, biomathematical models, and patient clinical information, this investigation assesses which pretreatment variables have a sex-specific impact on the survival of glioblastoma patients. Pretreatment MR images of 494 glioblastoma patients (299 males and 195 females) were segmented to quantify tumor volumes. Cox proportional hazard (CPH) models and Students t-tests were used to assess which variables were associated with survival outcomes.\n\nResultsAmong males, tumor (T1Gd) radius was a predictor of overall survival (HR=1.027, p=0.044). Among females, higher tumor cell net invasion rate was a significant detriment to overall survival (HR=1.011, p<0.001). Female extreme survivors had significantly smaller tumors (T1Gd) (p=0.010 t-test), but tumor size was not correlated with female overall survival (p=0.955 CPH). Both male and female extreme survivors had significantly lower tumor cell net proliferation rates than other patients (M p=0.004, F p=0.001, t-test). Additionally, extent of resection, tumor laterality, and IDH1 mutation status were also found to have sex-specific effects on overall survival.\n\nConclusionDespite similar distributions of the MR imaging parameters between males and females, there was a sex-specific difference in how these parameters related to outcomes, which emphasizes the importance of considering sex as a biological factor when determining patient prognosis and treatment approach.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Clinically Important sex differences in GBM biology revealed by analysis of male and female imaging, transcriptome and survival data
Wei Yang, Nicole M. Warrington, … Joshua B Rubin·bioRxiv·Dec 12, 2017
- Sex-specific T cell exhaustion drives differential immune responses in glioblastoma
J. Lee, M. Nicosia, … J. D. Lathia·bioRxiv·Aug 17, 2022
- Gonadal sex patterns p21-induced cellular senescence in mouse and human glioblastoma
L. Broestl, L. Grandison, … J. B. Rubin·Communications BiologyPeer-reviewed·Aug 2, 2022
- Sex Differences in MRI-Based Metrics of Glioma Invasion and Brain Mechanics
B. J. Anderies, S. F. Yee, … K. R. Swanson·bioRxiv·Nov 21, 2020
- EGR1 drives sex-differences in glioblastoma tumorigenicity
Thamara J. Abouantoun, Lorida Llaci, … Robi David Mitra·bioRxiv·May 16, 2025
- miR-644a is a tumor cell-intrinsic mediator of sex bias in glioblastoma
E. S. Hong, S. Z. Wang, … A. Dhawan·bioRxiv·Mar 11, 2024